Nykturia: diagnosis, classification and treatment

Česká verzia

Authors: J. P. Weiss; A. C. Weinberg; C. L. Lee; J. G. Blavais
Published in the journal: Urol List 2008; 6(1): 12-19

Summary

One of the most common reasons for interrupted sleep in the general adult population is nocturia – waking (at least once) during the night to urinate. The etiology of nocturia falls into five broad categories: a) nocturnal polyuria (NP); b) low nocturnal bladder capacity (NBC) despite normal global bladder capacity; c) diminished global bladder capacity; d) mixed (a combination of NP and low bladder capacity); e) global polyuria. These categories are derived from the 24 hour voiding diary wherein each voided volume and its corresponding time is entered. Thus, the etiology of nocturia is multifactorial and often unrelated to an underlying urologic condition. Various studies have shown cause-specific therapy to decrease the severity of nocturia, although further studies are needed to improve outcomes and maximize safety of treatment.

Key words:
nocturia, voiding diary, polyuria, bladder capacity

Zdroje

1. Kerrebroeck P, Abrams P, Chaikin D et al. The standardisation of terminology in nocturia: report from the Standardisation Sub-committee of the international Continence Society. Neurourol Urodyn 2002; 21(2):179-183.

2. Naitoh P, Kelly TL, Enqlund C. Health effects of sleep deprivation. Occup Med 1990; 5(2): 209-237.

3. Hetta J, Rimón R, Almqvist M. Mood alterations and sleep. Ann Clin Res 1985; 17(5): 252-256.

4. Lindberg E, Janson C, Gislason T et al. Sleep disturbances in a young adult population: can gender differences be explained by differences in psychological status? Sleep 1997; 20(6): 381-387.

5. Broman JE, Lundh LG, Hetta J. Insufficient sleep in the general population. Neurophysiol Clin 1996; 26(1): 30-39.

6. Binq MH, Moller LA, Jennum P et al. Prevalence and bother of nocturia, and cause of sleep interruption in a Danish population of men and women aged 60-80 years. BJU Int 2006; 98(3): 599-604.

7. Kerrebroeck P. Nocturia and Tamsulosin OCAS. European Urology Supplements; 6(12): 723-727.

8. Asplund R, Aberg H. Nocturnal micturition, sleep and well-being in women of ages 40-64 years. Maturitas 1996; 24(1-2): 73-81.

9. Barker JC, Mitteness LS. Nocturia in the elderly. Gerontologist 1988; 28(1): 99-104.

10. Stewart RB, Moore MT, May FE et al. Nocturia: a risk factor for falls in the elderly. J Am Geriatr Soc 1992; 40(12): 1217-1220.

11. Kujubu DA, Sherif RA. Evaluation of nocturia in the Elderly. The Premanete Journal, Winter 2007; 11(1): 37-39.

12. Suqaya K, Nishijima S, Owan T et al. Effects of walking exercise on nocturia in the elderly. Biomed Res 2007; 28(2): 101-105.

13. Donahue JL, Lowenthal DT. Nocturnal polyuria in the elderly person. Am J Med Sci 1997; 314(4): 232- 238.

14. Asplund R. The nocturnal polyuria syndrome (NPS). Gen Pharmacol 1995; 26(6): 1203-1209.

15. Gourova LW, van de Beek C, Spiqt MG et al. Predictive factors for nocturia in elderly men: a cross sectional study in 21 general practices. BJU Int 2006; 97(3): 528-532.

16. Yoshimura K, Terada N, Matsui Y et al. Prevalence of and risk factors for nocturia: Analysis of a health screening program. Int. J Urol 2004; 11(5): 282-287.

17. Saito M, Kondo A, Kato T, Yamada Y. Frequencyvolume charts: comparison of frequency between elderly and adult patients. Br J Urol 1993; 72(1): 38-41.

18. van Cauter E, Copinschi G. Altered hormonal secretions in aging: roles of sleep and circadian rhythms. Aging Male 1998; 1(Suppl): 8.

19. Fitzqerald MP, Litman HJ, Link C, McKinlay JB. The association of nocturia with cardiac disease, diabetes, body mass index, age and diuretic use: results from the BACH survey. J Urol 2007; 177(4): 1385- 1389.

20. Kripke DF, Garfinkel L, Winqard DL et al. Mortality associated with sleep duration and insomnia. Arch Gen Psychiatry 2002; 59(2): 131-136.

21. Coyne KS, Zhou Z, Bhattacharyya SK et al. The prevalence of nocturia and its effect on health-related quality of life and sleep in a community sample in the USA. BJU Int 2003; 92(9): 948-954.

22. van Dijk L, Kooij DG, Schellevis FG. Nocturia in the Dutch adult population. BJU Int 2002; 90(7): 644-648.

23. Schatzl G, Temml C, Schmidbauer J et al. Crosssectional study of nocturia in both sexes: analysis of a voluntary health screening project. Urology 2000; 56(1): 71-75.

24. Tikkinen KA, Temmela TL, Huhtala H, Auvinen A. Is nocturia equally common among men and women? A population based study in Finland. J Urol 2006; 175(2): 596-600.

25. Yoshimura K, Kamoto T, Tsukamoto T et al. Seasonal Alterations in Nocturia and Other Storage Symptoms in Three Japanese Communities. Urology 2007; 69(5): 864-870.

26. Abrams P, Cardozo L, Fall M et al. The standardisation of terminology of lower urinary tract function: report from the Standardisation Sub-committe of the International Continence Society. Neurourol Urodyn 2002; 21(2): 167-178.

27. Weiss JP, Blaivas JG, Stember DS, Chaikin DC. Evaluation of the etiology of nocturia in men: the nocturia and nocturnal bladder capacity indices. Neurourol Urodyn 1999; 18(6): 559-565.

28. Rembratt A, Weiss J, Robertson G. Pathogenesis of nocturia in the elderly: relationship of functional bladder capacity to nocturnal urine output. J Urol 2001; 165(Suppl): 250.

29. Kirkland JL, Lye M. Levy DW, Banerjee AK. Patterns of urine flow and electrolyte excretion in healthy elderly people. Br Med J 1983; 287(6406): 1665-1667.

30. Asplund R, Aberg H. Diurnal variation in the levels of antidiuretic hormone in the elderly. J Intern Med 1991; 229(2): 131-134.

31. Ozawa T, Oyanaqi K, Tanaka H et al. nucleus in a patient with multiple system atrophy with abnormal circadian rhythm of arginine-vasopressin secretion into plasma. J Neurol Sci 1998; 154(1): 116-121.

32. Graugaard-Jensen C. Ritting S.Djurhuus JC. Nocturia and circadian blood pressure profile in healthy male volunteers. J Urol 2006; 176(3): 1034-1039.

33. Matthiesen TB, Ritting S, Norgaard JP et al. Nocturnal polyuria and natriuresis in male patients with nocturia and lower urinary tract symptoms. J Urol 1996; 156(4): 1292-1299.

34. Natsume O. A clinical investigation of nocturnal polyuria in patients with nocturia: a dumal variation in arginine vasopressin secretion and its relevance to mean blood pressure. J Urol 2006; 176(2): 660-664.

35. Weiss JP, Blavis JG. Nocturia. J Urol 2000; 163(1): 5-12.

36. Lose G, Lalos O, Freeman RM et al. Efficacy of desmopressin (Minirin) in the treatment of nocturia: a double-blind placebo-controlled study in women. Am J Obstet Gynecol 2003; 189(4): 1106-1113.

37. Mattiasson A, Abrams P, Kerrebroeck P et al. Efficacy of desmopressin in the treatment of nocturia: a double-blind placebo-controlled study in men. BJU Int 2002; 89(9): 855-862.

38. Le Fanu J. The value of aspirin in controlling the symptoms of nocturnal polyaria. BJU Int 2001; 88(1): 126-127.

39. Addla SK, Adeyoju AB, Nelson D, O'Reilly P. Diclofenac for treatment of nocturia caused by nocturnal polyuria: a prospective, randomised, doubleblind, placebo-controlled crossover study. Eur Urol 2006; 49(4): 720-725.

40. Endeshaw YW, Johnson TM, Kutner MH at al. Sleep-disordered breathing and nocturia in older adults. J Am Geriatr Soc 2004; 52(6): 957-960.

41. Fitzgerald MP, Mulligan M, Parthasarathy S. Nocturic frequency is related to severity of obstructive sleep apnea, improves with continuous positive airways treatment. Am J Obstet Gynecol 2006; 194(5): 1399-1403.

42. Marqel D, Shochat T, Getzler O et al. Continuous positive airway pressure reduces nocturia in patients with obstructive sleep apnea. Urology 2006; 67(5): 974-977.

43. Yalkut D, Lee LY, Grider J et al. Mechanism of atrial natriuretic peptide release with increased inspiratory resistance. J Lab Clin Med 1996; 128(3): 322-328.

44. Partinen M. Epidemiology of obstructive sleep apnea syndrome. Curr Opin Pulm Med 1995; 1(6): 482-487.

45. Guilleminault C, Lin CM, Goncalves MA, Ramos E. A prospective study of nocturia and the duality of life of elderly patients with obstructive sleep apnea or sleep onset insomnia. J Psychosomatic Res 2004; 56(5): 511-515.

46. Johnson TM 2nd, Jones K, Williford WO et al. Changes in nocturia from medical treatment of bening prostatic hyperplasia: secondary analysis of the department of veterans affairs cooperative study trial. J Urol 2003; 170(1): 145-148.

47. Blaivas JG, Stember DS, Weiss JP. Etiology of voiding symptoms in men: correlation of individual AUA symptom scores with urodynamic and diary parameters. Neurourol Urodyn 1998; 17: 398-399.

48. Cardozo L, Lisec M, Millard R et al. Randomized, double-blind placebo-controlled trial of the once daily antimuscarinic agent solifenacin succinate in patients with overactive bladder. J Urol 2004; 172(5 Pt 1): 1919-1924.

49. Abrams P, Swift S. Solifenacinis effective for the treatment of OAB dry patients: a pooled analysis. Eur Urol 2005; 48(3): 483-487.

50. Chapple CR, Cardozo L, Steers WD, Govier FE. Solifenacin significantly improves all symptoms of overactive bladder syndrome. Int J Clin Pract 2006; 60(8): 959-966.

51. Rudy D, Cline K, Harris R et al. Multicenter phase III. Trial studying trospium chloride in patients with overactive bladder. Urology 2006; 67(2): 275- 280.

52. Zinner N, Gittelman M, Harris R et al. Trospium chloride improves overactive bladder symptoms: a multicenter phase III trial. J Urol 2004; 171(6 Pt 1): 2311-2315.

53. Nitti VW, Dmochowski R, Appell RA et al. Efficacy and tolerability of tolterodine extendedrelease in continent patients with overactive bladder and nocturia. BJU Int 2006; 97(6): 1262- 1266.

54. Rackley R, Weiss JP, Rovnej ES et al. Nighttime dosing with tolterodine reduces overactive bladderrelated nocturnal micturitions in patients with overactive bladder and nocturia. Urology. 2006; 67: 731-6.

55. Kaplan SA, Roehrborn CG, Dmochowski R et al. Tolterodine extended release improves overactive bladder symptoms in men with overactive bladder and nocturia. Urology 2006; 68(2): 328- 332.

56. Blake-James BT, Rashidian A, Ikeda Y, Emberton M. The role of anticholinergics in men with lower urinary tract symptoms suggestive of benign prostatic hyperplasia: a systematic review and meta-analysis. BJU Int 2007; 99(1): 85-96.

57. Weiss JP, Blaivas JG, Jones M et al. Age related pathogenesis of nocturia in patients with overactive bladder. J Urol 2007; 178(2): 548-551.

58. Weiss JP, Blaivas JG, Stember DS, Brooks MM. Nocturia in adults: etiology and classification. Neurourol Urodyn 1998; 17(5): 467-472.

59. Paick JS, Ku JH, Shin JW et al. Alpha-blocker monotherapy in the treatment of nocturia in men with lower urinary tract symptoms: a prospective study of response prediction. BJU Int 2006; 97(5): 1017-1023.

60. Koseoglu H, Aslan G, Ozdemir I, Esen A. Nocturnal polyuria in patients with lower urinary tract symptoms and response to alpha-blocker therapy. Urology 2006; 67(6): 1188-1192.

61. Adam P. Evaluation and management of diabetes insipidus. Am Fam Physicain 1997; 55(6): 2146- 2153.